Thursday, June 1, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor

May 17, 2016
in Cancer
0
Share on FacebookShare on Twitter
IMAGE

Not every breast cancer tumor follows the same path to grow. Some tumors have the assistance of myeloid-derived suppressor cells (MDSCs), a diverse type of immune cell involved in the suppression of the body's response against tumors. How breast cancer cells recruit MDSCs is not completely understood, but in a paper released today in Nature Cell Biology, Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage MDSCs.

"There are alternative paths a tumor may take without the MDSCs, but those cancer cells that take the mTOR path of activity tend to have more MDSCs through the production of granulocyte-colony stimulating factor (G-CSF), which drives the accumulation of MDSCs," said corresponding author Dr. Xiang Zhang, a McNair Scholar and assistant professor of molecular and cellular biology at Baylor College of Medicine.

Knowing how cancer cells and MDSCs interact with each other helps researchers understand the events that may lead to tumor growth and metastasis and identify potential therapeutic targets. For instance, "determining that a patient's tumor is using the mTOR pathway would indicate that the cancer cells are more likely to depend on MDSCs for progression," said Zhang, who also is with the Lester and Sue Smith Breast Center at Baylor. "This information suggests that, in this case, available therapies for mTOR combined with therapies for MDSCs represent potential therapeutic strategies." Tumors that do not use the mTOR signaling pathway would not be expected to respond as well to the same therapies.

The discovery of Zhang and colleagues is much in line with the concept of personalized medicine. "People talk about the specific mutations one patient's tumor has that are not in another patient's tumor. The same type of tumors having different mutations may warrant different treatments; that is personalized medicine," explained Zhang. "We are trying to come from a different angle. We are trying to enrich this concept by saying that not only tumor-intrinsic characteristics are different from patient to patient, but, related to that, there is also diversity in terms of the immune components. Different tumors may evolve via different characteristics of the tumor and the immune response."

MDCSs are just one type of aberrant immune cell associated with the tumor. "In addition, there are other immune cells associated with the tumor – monocytes, macrophages, different subsets of T cells – that can either attack or help the tumor. All those cells may vary from patient to patient, and we don't really understand that yet," said Zhang.

In addition, MDSCs also play a role in non-cancer situations. For instance, in chronic inflammation, these cells try to suppress the inflammation; in this case, they play a pro-health role. So, "simply eliminating all MDSCs to treat cancer may likely result in negative side effects, such as autoimmune disease. That's why it's necessary to further characterize the diversity, to find the specific subsets of MDSCs that are tumor specific," said Zhang.

###

Other contributors to this work include Thomas Welte from Baylor and the Diana Helis Henry Medical Research Foundation, New Orleans; Ik Sun Kim, Lin Tian, Xia Gao, Hai Wang, June Li, Xue B. Holdman, Jason I. Herschkowitz, Adam Pond, Sarah Kurley, Tuan Nguyen, Lan Liao, Lacey E. Dobrolecki, Qianxing Mo, Dean P. Edwards, Shixia Huang, Li Xin, Jianming Xu, Yi Li, Michael T. Lewis, Thomas F. Westbrook, and Jeffrey M. Rosen (co-corresponding author), all from Baylor; and Guorui Xie, Lan Pang and Tian Wang from the department of microbiology and immunology at The University of Texas Medical Branch, Galveston.

This work is supported by National Cancer Institute (CA151293, CA16303), Breast Cancer Research Foundation, US Department of Defense (DAMD W81XWH-13-1-0195), Susan G. Komen (CCR14298445), McNair Medical Institute, and Diana Helis Henry Medical Research Foundation.

Media Contact

Dana Benson
[email protected]
713-798-4710
@bcmhouston

https://www.bcm.edu/news

Share25Tweet16Share4ShareSendShare
  • blank

    Why expensive wine appears to taste better

    71 shares
    Share 28 Tweet 18
  • Artificial intelligence system predicts consequences of gene modifications

    67 shares
    Share 27 Tweet 17
  • “You must have a preference”: How does lack of preference affect joint decision-making?

    67 shares
    Share 27 Tweet 17
  • Finally solved! The great mystery of quantized vortex motion

    64 shares
    Share 26 Tweet 16
  • New 3D printing technique ready to advance manufacturing

    64 shares
    Share 26 Tweet 16
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    75 shares
    Share 30 Tweet 19
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Element creation in the lab deepens understanding of surface explosions on neutron stars

Why expensive wine appears to taste better

Study finds that eight factors put Black adults at greater risk of early death

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 206 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In